this is biotech-no timelines in the last update have been

New Post Public Reply Private Reply Replies (0) Message Board
microcaps rayludwiczak #7214
625
this is biotech-no timelines in the last update have been violated and i believe you are playing with free shares due to flipping-so wheres the panic?

I've explained the business process numerous times, so theres no need to explain such continuously -that process has not changed

penny traders in particular seem to get the notion that nothing is being done unless theres an update every day

NNLX has explained the current testing process/progress to the extent permitted by their two NDA partners

what are we supposed to say??? what do you expect us to do- kidnap the ceo and hold him at gunpoint until he elaborates??? Bret cant speed up the process

biotech is a process- they have to process test results to present to the FDA and for peer reviewed papers

besides, i'm not paid for my posts or for babysitting this board-the world needs more quiet rather than panic=panic doesnt contribute anything-it actually slows the process

Friday, August 7, 2020 10:29:11 AM

Post#
6969
of 6989
(Total Views: 134)
Posted On: 08/07/2020 8:22:19 AM

Posted By: Eudius

Update
NanoLogix Sub 1-Hour Covid-19 Detection Test Further Developments

NanoLogix Begins Collaborative Efforts With Diagnostic Company and an Independent Laboratory


NanoLogix announces it has begun working with two entities to refine and further develop its patent-pending Rapid Viral Assay for COVID19 and other viruses. One is a West Coast diagnostic company and the other a long-established independent Houston laboratory.

The overall intent of this work is to obtain results to enable a detailed submission of those results to the US FDA for the purpose of receiving an Emergency Use Authorization, enabling use of the technology as a Point of Care (POC) rapid test. Secondary benefits should be publication of the resulting data in the form of at least two peer-reviewed science/medical journal papers. Grant applications are anticipated by at least one of the partners to the work. The projections for the timeline for the work range from one+ month for the independent laboratory to more than three months for the diagnostic company.

While we have achieved results in less than one hour with our own laboratory work, indications from one of the entities are that the test can potentially be streamlined to the point where results may be obtained in as little as twenty minutes in a form that makes the test more user and consumer friendly. This projected ease of use positions the assay for potential home use if and when it is approved by the FDA.

NanoLogix has entered into mutual confidentiality agreements with both involved groups. We faithfully respect those agreements as essential to the success of business and technology development. In the past, when we have released information mentioning arrangements with others, such as the US EPA, the University of Texas Health Science Center in Houston, Battelle Biomedical research Center, and individuals recently employed or otherwise associated with NanoLogix, those groups began receiving calls and contacts from persons identifying themselves as shareholders of NanoLogix. The calls ranged from in subject from simple curiousity to demands to reveal the nature of the technology development and business relationship with NanoLogix. The effects were potentially damaging to NanoLogix and its interests, to include investors. We will not release further information regarding the recent associations until all parties are prepared to do so.

This press release or update contains statements, which may constitute "forward- looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.



Read More: https://investorshangout.com/Nanologix-Inc-NN...z6XnBP3PnR
1

Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 423

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 330

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 346

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 344

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 220

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 477

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 103

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 102

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 378

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 323

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Breast Aesthetics: Embracing Natural Beauty

Updated Category News Views 467

Global Surgeons Advocate for Natural Breast Aesthetics In a groundbreaking initiative, a coalition of prominent plastic surgeons has introduced a new standard for breast augmentation emphasizing 'Natural Breast Beauty'. This initiative, presented at an international symposium in Milan, arose from increasing concerns regarding aesthetically unpleasing results and the...

Continue Reading
Pony AI Receives Strong Buy Ratings from Top Financial Firms

Updated Category News Views 189

Pony AI's Promising Future with Top Ratings Pony AI has recently come into the spotlight after receiving a positive assessment from two major financial institutions, Bank of America and Goldman Sachs. Both firms have initiated coverage on the company, marking it with a favorable ‘buy’ rating. Bank of America has set an ambitious price target of $18, indicating a...

Continue Reading
Rapport Therapeutics: Insights on Neuropsychiatry Conference Participation

Updated Category News Views 116

Rapport Therapeutics at the Neuropsychiatry Summit BOSTON and SAN DIEGO – Rapport Therapeutics, Inc. (NASDAQ: RAPP), a clinical-stage biotechnology company, is making headway in the realm of neurological and psychiatric disorders through its small molecule precision medicines. The company is gearing up to participate in the upcoming TD Cowen's 5th Annual Novel...

Continue Reading
Innovative Credit Card Security Solution by InventHelp Inventor

Updated Category News Views 228

Innovative Credit Card Security Solution An inventor has come up with a groundbreaking idea to guard credit and debit card users against unauthorized transactions. This invention, termed the CREDIT CARD SECURITY LOCK, aims to provide an extra layer of protection, ensuring that only the legitimate cardholder can access their funds. Revolutionizing Payment Security This...

Continue Reading
Polling Insights: Vance and Walz's Debate Performance Analyzed

Updated Category News Views 87

Debate Highlights Between Vance and Walz In a recent debate that captured public attention, Minnesota Governor Tim Walz and Senator J.D. Vance (R-Ohio) engaged in a spirited discussion that left many viewers with strong opinions. According to flash polls conducted by CNN, Vance emerged slightly ahead in the eyes of debate watchers. Polling Results Breakdown The debate was...

Continue Reading